Skip to main content

Table 2 Synopsis of recent case reports decribing various phototherapeutic alternatives in a number of sclerotic rarities. [Categories: A – double-blind, randomized, placebo-controlled; B – open, randomised; C – open, non-randomized; D – case series; E – case report]

From: UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review

Disease Therapy Dosage Experience Comments
Eosinophilic fasciitis UVA180 low-dose E benefit, no valid data available
  PUVA81 medium-dose E  
Pansclerotic morphea UVA84 low-dose E possible efficacy as an adjunct therapy,
  UVA183 low-dose E no valid data available
  PUVA85,86 medium-dose E  
Scleromyxedema PUVA90–92 high-dose E controversial, possible efficacy as an adjunct therapy, no valid data available
Scleredema adultorum Buschke PUVA95,96 high-dose E, D possible therapeutic alternative, cream therapy, no valid data available
POEMS UVA198 low-dose E benefit, no valid data available
Bleomycin-induced scleroderma UVA199 low-dose E limited success, no valid data available
Pansclerotic porphyria cutanea tarda UVA1101 medium-dose E benefit, no valid data available